Adage Capital Partners
KROS icon

Adage Capital Partners’s Keros Therapeutics KROS Stock Holding History

Adage Capital Partners’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-230,000
Closed -$10.5M – 907
2024
Q2 		$10.5M Buy
230,000
+40,000
+21% +$1.83M 0.02% 598
2024
Q1 		$12.6M Buy
+190,000
New +$12.6M 0.02% 558